Advances in Lymph Node Mapping and Sentinel Lymph Node Biopsy for Head and Neck Cancers

Organized by the SNMMI Outreach Domain.

Advances in Lymph Node Mapping and Sentinel Lymph Node Biopsy for Head and Neck Cancers

Date: July 21 at 7:00 - 8:00 pm ET
Fee: Complimentary 
CE Credit is available for this webinar.

Registration for this event is now closed. A link to the recorded session will be available here soon.

This course will include both a nuclear medicine perspective and a head and neck surgeon’s perspective on lymph node mapping and sentinel lymph node biopsy and the role of these procedures in patient management. Participants will have increased knowledge around the goals of lymph node imaging, mapping, and localization, including:

  1. appropriate use criteria of lymphoscintigraphy and the clinical value it provides;
  2. the clinical advanced and associated trial data on the use of radiotracers for lymph node mapping and localization in patients with head and neck cancers; and
  3. integration of the latest evidence on the use of radiotracers in lymph node mapping and localization and the selection of the appropriate radiotracers to optimize efficient resource utilization, patient experience, and patient outcomes.

Speakers:

Renee Moadel, MD
Attending Nuclear Medicine Physician
Montefiore Medical Center
New York, NY

Steven Chang, MD, MS, FACS
Division Chief, Head and Neck Cancer Surgery
Henry Ford Cancer Institute
Detroit, MI

CE Accreditation

CME Accreditation – AMA PRA Credits

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this online program for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must complete the online assessment and evaluation available after the program.

 

VOICE Credit statement

The Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS), through its Verification of Involvement in Continuing Education (VOICE) program, has approved this webinar for 1.0 continuing education hour (CEHs) of Category A+ credit.

VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT (as Category A and A+ credit). In order to receive CE credit, technologists must complete the online assessment and evaluation available after the program.

 

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

 

Universal Activity Number: 0210-0000-20-017-H04-P Topic designations: H04=General Pharmacy Topics. This activity has been designated as knowledge-based CPE for Pharmacists. Total available credit for pharmacists is 1.0 hours or 0.1 CEUs. 

 

To receive CPE credit, pharmacists must complete the post-program assessment and evaluation. You will have 3 attempts to pass the assessment with a score of 80%. Credit details will be uploaded to the National Association of Boards of Pharmacy (NABP) via the CPE Monitor within 14 days of evaluation completion. Evaluation must be completed by February 29, 2020. Pharmacists must include their NABP eProfile ID, which can be obtained at www.MyCPEmonitor.net.